Sunday, November 17, 2024
Happening Now

Report: New owner jacks up price of cancer drug

Prices for a 40-year-old cancer drug called lomustine have skyrocketed nearly 1,400 percent since 2013. The Wall Street Journal reports the price hike came after a company called NextSource acquired the drug. Source

Share